person
as of 2026-07-01Bill Deakin, Professor
Bill Deakin, ProfProfessor Bill Deakin
ORCID 0000-0002-2750-962X
at a glance
Roles: Principal Investigator, Author
KOL signal score 4
2 publications · 0 high-value
Cross-drug reach: 2 competitor drugs
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
University of Manchester
Roles
Principal Investigator, Author
KOL signal
4
Publications
2 (0 high-value)
Trial investigator
no
Publishes on
2 drugs
Trials led
3
The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms
NCT02928965Phase 2Completed
A Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Males
NCT02935725Phase 1Completed
Effects of Ketamine and Risperidone on Cognition
NCT01140620Phase 4Completed
Publications & congress
1
Effects of ulotaront on brain circuits of reward, working memory, and emotion processing in healthy volunteers with high or low schizotypy.
Schizophrenia (Heidelberg, Germany) · 2023
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
publishes on
drug
drug